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Background: In cortical and hippocampal brain slice experiments, the viability of processed tissue is usually judged
by the amplitude of extracellularly-recorded seizure-like event (SLE) activity. Surprisingly, the suitability of this
approach for evaluating slice quality has not been objectively studied. Furthermore, a method for gauging the
viability of quiescent tissue, in which SLE activity is intentionally suppressed, has not been documented. In this
study we undertook to address both of these matters using the zero-magnesium SLE model in neocortical slices.
Methods: Using zero-magnesium SLE activity as the output parameter, we investigated: 1) changes in the pattern
(amplitude, frequency and length) of SLE activity as slice health either deteriorated; or was compromised by altering
the preparation methodology and; 2) in quiescent tissue, whether the triggering of high frequency field activity
following electrode insertion predicted subsequent development of SLE activity— and hence slice viability.
Results: SLE amplitude was the single most important variable correlating with slice viability, with a value less than
50 μV indicative of tissue unlikely to be able to sustain population activity for more than 30–60 minutes. In
quiescent slices, an increase in high frequency field activity immediately after electrode insertion predicted the
development of SLE activity in 100% of cases. Furthermore, the magnitude of the increase in spectral power
correlated with the amplitude of succeeding SLE activity (R2 40.9%, p < 0.0001).
Conclusion: In conclusion, the findings confirm that the amplitude of population activity is a suitable field potential
parameter for judging brain slice viability — and can be applied independent of the mechanism of tissue
activation.
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The in vitro brain slice preparation has become an
indispensable tool for neurophysiological research
since its introduction nearly 50 years ago by Henry
McIlwain [1]. The popularity of this method stems from
its unique balance of ease of use, high controllability of
experimental conditions and retained tissue function at
molecular, cellular and network levels.
An important issue for slice experimentalists is how best
to assess tissue viability from one slice to another — and
in so-doing make a sound judgment as to whether to
exclude a given sample from experimental testing. This
should be of more than just passing interest, because
variation in slice condition from trial to trial has potential* Correspondence: logan.voss@waikatodhb.health.nz
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stated.to greatly confound results. In slice studies in which
seizure-like event (SLE) field potentials are the main
output, event amplitude is the go-to criterion for inclusion
or exclusion [2]. Surprisingly, this practice has been
adhered to despite a lack of firm scientific evidence for
its justification [3,4].
A separate (but related) issue is how best to judge slice
viability in protocols in which SLE activity is intentionally
suppressed. There are occasions when experimental
protocols require comparison groups in which SLE
activity is inhibited [5] ― and there are currently no
recognized means of classifying slice viability under
these conditions.
In this study we sought to address both of these matters
using the zero-magnesium SLE model. Accordingly, the
study was divided broadly into two parts. In the first, we
characterized the SLE parameter(s) that correlated withd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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was to determine unequivocally whether SLE amplitude
(or an alternative measure) is a reliable means of judging
slice condition. In the second, we explored the anecdotal
finding that insertion of extracellular electrodes into qui-
escent tissue sometimes induces a rapidly waning burst of
high frequency activity in the field potential recording.
We hypothesized that appearance of this high fre-
quency activity reflects the response of healthy tissue
to the trauma of electrode insertion ― and could be
used to evaluate slice viability when SLE activity has
been suppressed.Results
An example of the pattern of seizure-like event extra-
cellular field potential activity induced by removal of
magnesium from the artificial cerebrospinal fluid
(aCSF) is shown in Figure 1. The seizure-like bursts
are typical of those recorded under zero-magnesium
conditions.Figure 1 Example of the pattern of zero-magnesium SLE activity
recorded from one slice showing a compressed time view (top)
encompassing multiple SLEs and an expanded view (bottom) of a
single SLE.Pattern of SLE activity in deteriorating/compromised
slices
SLE activity changed variably over time as the tissue
deteriorated (Table 1). While event amplitude, frequency
and length all trended downwards over time, the only
significant change was a reduction in event amplitude.
The data indicate that SLE amplitude of less than 50 μV
is indicative of tissue that is poorly viable and may not
be able to sustain population activity for more than
30–60 minutes. However, it is important to note that
this is a generalization based on variable data. For example,
in two cases, SLE amplitude was greater than 200 μV
within 30 minutes of all activity ceasing. Furthermore, in
one slice SLE amplitude at the beginning of the recording
was 10 μV but continued to deliver stable activity for
upwards of 7 hours.
The alterations made to the slice preparation methods
were designed to deliberately undermine tissue condition―
with the aim of establishing unequivocally whether
low SLE amplitude correlated with poor slice viability.
The results were clear in showing that all three interventions
resulted in significantly lower SLE amplitude compared to
our “standard” protocol (Table 2). The data confirm that a
peak-to-peak amplitude value of approximately 50 μV
or less is a good indication that tissue condition has
been compromised. With the exception of a lower SLE
frequency in the tap water group, event amplitude was the
only variable affected. Under the conditions tested in this
study and for the analysis methods employed, we can
conclude that event amplitude is the single most useful
variable for assessing slice viability.
Quiescent tissue viability correlates
An example of the pattern of activity induced by electrode
placement into quiescent tissue is shown in Figure 2. Of
the 42 recordings, SLEs developed in 36 cases. In these, the
mean(SD) change in spectral power following electrode
insertion was 382.7(554.5)%; compared to 5.7(12.4)%
in the 6 “non-responders”. The difference is statistically
significant (p = 0.004, Mann–Whitney test). SLEs occasion-
ally (8/42) developed even though no noticeable change
(judged by eye to be a change of <20%) in high frequencyTable 1 SLE characteristics as neocortical slice tissue
deteriorated from 1 hour after starting recording (Seg 1)
to 1–2 hours before all activity stopped (Seg 2) to
30 minutes before all activity stopped (Seg 3)
Frequency (/min) Amplitude (μV) Length (s)
Seg 1 6.4(2.5-25.8) 126.4(9.2-1174.6)* 1.0(0.4-1.4)
Seg 2 4.5(1.3-13.2) 55.0(15.9-1466.6) 1.1(0.3-1.3)
Seg 3 3.7(1.8-18.0) 25.6(7.5-252.1) 0.7(0.3-1.2)
*p< 0.01, compared to Seg2 and Seg3 (Friedman Test, Dunn’s Multiple comparisons).
Data are median(range).
Table 2 Median (range) SLE characteristics using preparation methods designed to impair tissue viability
Frequency (/min) Amplitude (μV) Length (s) % Active locations
“Standard” conditions 3.2(0.6-11.0) 173.0(32.2-1247.1) 1.7(0.6-8.7) 57.5
Long CO2 2.5(0.5-11.1) 52.8(9.9-840.1)** 2.0(1.1-5.1) 60.3
Slicing delay 30 mins 2.5(0.6-9.7) 63.1(13.2-236.5)** 2.0(1.4-3.7) 40.8
Unfiltered tap water 2.0(0.6-31.8)* 36.0(10.3-424.7)** 1.8(0.7-3.3) 58.9
“Standard” conditions are defined in the methods section.
*p = 0.0039, compared to “Standard” conditions (Mann–Whitney).
**p = 0.0001, compared to “Standard” conditions (Mann–Whitney).
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is, SLEs developed in 100% of instances where the increase
in power was >20% (28/42). Furthermore, the greater the
spectral power increase, the larger the amplitude of the
SLEs that subsequently developed (R2 40.9%, p < 0.0001);
and (to a lesser extent), the higher the SLE frequency
(R2 15.9%, p < 0.009) (Figure 3). SLE frequency was
also positively correlated with the length of time the
slices were held in normal aCSF prior to recording,
which may account for some of the variability in SLE
frequency outcome. There was no correlation between
normal aCSF hold time and either SLE amplitude (R2 0.2%,
p = 0.78) or SLE length (R2 0.005%, p = 0.97).
When slice viability was intentionally compromised
(n = 6, from one animal), the change in spectral power
following electrode insertion was 5.1(−7.7-126.5)%, com-
pared to 82.9(−19.5-2378.6)% under standard conditions
(p = 0.036, Mann–Whitney test). In the compromised
group, SLEs developed in only 50% of cases, compared
to 86% under standard slicing conditions — with a
median(range) amplitude of 13.7(0–54.9) μV and 82.1
(0–332.2) μV, respectively (p = 0.02, Mann–Whitney test) ―
confirming the relationship between slice viability, the tissue
response to electrode insertion and SLE development.Figure 2 Example showing the increase in high frequency field
potential activity triggered by electrode insertion into the tissue.Discussion
In this study we addressed two questions relating to
the evaluation of cortical brain slice viability. Firstly,
when recording SLE activity under zero-magnesium
conditions, is event amplitude a valid method for
judging the health of the slice? Event amplitude is
widely used to evaluate slice condition at the beginning of
an experiment, with many researchers applying amplitude-
based exclusion thresholds [2,4]. The logic is sound,
because a greater number of viable cells will be potentially
recruitable for each event in a healthier slice. However, the
amplitude of population activity is not governed solely by
the number of active units, but also the synchrony of those
units [6]. Thus, lower amplitude activity does not by a
priori mean fewer viable cells. It’s surprising then that
examination of the literature uncovers scant objective
investigation of this topic. In this study, we approached the
subject by quantifying SLE characteristics following inter-
ventions designed to be detrimental to tissue health. The
group comparisons confirmed that compromised tissue
tended to produce SLEs of lower amplitude. Furthermore,
the other measures of SLE activity did not associate with
slice condition, validating event amplitude as the most
suitable parameter. As a caveat to this, it should be noted
that the downward trend in event amplitude may be more
informative than the absolute value, making the choice of
threshold for slice exclusion/inclusion more difficult.
Secondly, we were interested in whether the tissue
response to electrode penetration could predict subsequent
SLE development; and hence identify healthy slices in which
SLE activity had been intentionally suppressed. The results
paralleled those of the first part of the study, showing that
the amplitude (power) of the high frequency response to
electrode-induced tissue trauma correlated with the ampli-
tude of SLE activity recorded from the same slice. In other
words, the amplitude of field potential population activity
per se reflects the underlying health status of the tissue,
independent of the method used to generate the activity.
In this study we used the zero-magnesium model of
epileptogenesis. This method has been widely used for
investigating mechanisms of epilepsy [7,8] and has also
been applied to the study of anaesthetic drug effects [9,10].
The model therefore has wide applicability in the field of
neurophysiology. Moreover, the two complementary facets
Figure 3 Correlations of SLE amplitude (a), frequency (b) and
length (c) with the% change in high frequency spectral power
triggered by electrode insertion into the tissue.
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to other slice models involving different methods of tissue
activation.Conclusions
In conclusion, the amplitude of population activity ―
independent of its mechanism of production ― is a




The Waikato Ethics Committee at Waikato University,
Hamilton, New Zealand approved all experimental
procedures (approval #859).
Artificial cerebrospinal fluid solutions
Unless otherwise stated, the solutions were made with
double distilled water and stored at 1–4°C for no longer
than 7 days. All solutions were bubbled with carbogen
(95% O2; 5% CO2) for at least 15 minutes before use.
Three solutions were used as follows (amounts in mM):
1) “Protective” aCSF for brain extraction and tissue
slicing: NaCl 92.7, KCl 3, MgCl2 19, NaH2PO4 1.2,
NaHCO3 24 and D-glucose 25 [11].
2) “Normal” aCSF for brain extraction and tissue
slicing: NaCl 125, KCl 2.5, MgCl2 1, CaCl2 2,
NaH2PO4 1.25, NaHCO3 26 and D-glucose 10.
3) “Zero-magnesium” aCSF lacking magnesium ions:
NaCl 124, KCl 5, CaCl2 2, NaH2PO4 1.25, NaHCO3
26 and D-glucose 10.
The composition of solutions 2) and 3) were designed to
ensure equal osmolarity, which was confirmed using an
RE388TX conductivity meter (EDT Instruments Ltd, UK),
at a frequency selected by the meter such that polarization
effects were minimized. The conductivities of the two solu-
tions were 1.578 S m − 1 and 1.558 S m− 1, respectively.
“Standard” procedures for tissue preparation
Adult male and female wild-type (129SV) mice were used to
obtain neocortical brain slices. Prior to decapitation and
brain dissection, the mice were anaesthetized with carbon di-
oxide (approximately 30 s exposure) until unresponsive to
paw pinch. The brain was freed from adjacent tissue and
placed into ice-cold “Protective” aCSF. The delay between
brain removal and slicing was not more than 10 minutes.
Immediately before slicing, the anterior and posterior
1–2 mm of the cerebral cortex was removed with a razor
blade. The tissue block (between Bregma −2 to −5) was
glued to a stainless steel stage for slicing into 7–9 400 μm
thick coronal sections using a vibratome (Campden Instru-
ments, UK). Slices were held in zero-magnesium aCSF solu-
tion to recover for at least an hour and a half prior to
recording at room temperature (22–27°C). For experimental
recording, slices were individually transferred to a
submersion-style recording bath (Tissue Recording System,
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zero-magnesium aCSF solution at a gravity-fed flow rate of
5.0 ml/min.
Extracellular field potential recording
SLE activity (see Figure 1) was recorded using a 50 μm
Teflon-coated tungsten electrode. The electrode was
referenced to a silver/silver-chloride disc electrode posi-
tioned in the recording bath, which also served as the
bath ground. The data was recorded with a 1000× gain,
low- and high pass filtered at 3000 Hz and 1.0 Hz respec-
tively (Model 1800 AC amplifier, A-M Systems, USA).
The data was collected using LabChart6 and Spike2 and
saved for later analysis using MATLAB (version 7.13.0.564,
R2011b, The MathWorks Inc., Natick Massachusetts
USA).
Experimental procedures 1: pattern of SLE activity in
compromised slices
This section was divided into two parts. In the first,
slices were established in the recording bath as above
and stable SLE activity identified. No minimum amplitude
threshold was applied because we made no assumptions
about the correlation between SLE amplitude and slice
viability. The aCSF solution flow was then stopped and
the recording continued until all SLE activity had stopped.
On occasions this required recordings to be continued
overnight to be sure all activity had ceased. Each recording
was subsequently analysed at 3 time-points for SLE
frequency, length and amplitude: 1) within 1 hour of
establishing the recording (seg1); 2) 1–2 hours before
all activity stopped (seg2) and; 3) within 30 minutes
of all activity stopping (seg3). The aim was to identify
changes in SLE activity as the slice deteriorated, thereby
providing an objective measure of slice health. Data was
collected from 11 slices (from 4 animals).
In the second, we changed aspects of the slice preparation
methodology so as to compromise tissue outcome. The aim
was to validate, under varying conditions, the outcomes
from the first part of the study. The following changes were
made to the standard methodology as described above and
SLE outcome comparisons made.
1) Longer (2 minutes, complete asphyxiation)
CO2 anaesthesia for mouse decapitation
(n = 38, 6 animals)
2) Whole brain held in “brain extract” solution
prior to slicing for a longer period (30 minutes)
(n = 23, 4 animals, respectively)
3) Unfiltered tap water used for aCSF solutions
(n = 33, 5 animals)
Once established in the recording bath, four locations
of equidistant separation (two from each hemisphere)were sequentially recorded from each slice. The amplitude,
frequency and length of SLE activity were averaged over 5
consecutive events from each location. If no SLE activity
was evident at any one location, this was noted as a
non-active site. Non-activity was defined as: 1) no SLEs
observed within 3 minutes of establishing the recording
or; 2) less than 5 SLEs recorded within 10 minutes of
establishing the recording. The total proportion of active
locations was calculated for each condition.Experimental procedures 2: viability testing in
SLE-quiescent tissue
Mouse cortical slices were prepared as per the standard
procedures outlined in section 2.3, with the exception that
the slices were maintained for the 1.5 hour post-slicing
period in normal aCSF to prevent SLE development. In
total, 16 slices were prepared from 2 animals, giving
42 recordings. For comparison, tissue preparation in a
separate group (6 slices from 1 animal) was intentionally
compromised by delaying slicing of the extracted brain by
60 minutes.
Thereafter, each slice was transferred to the recording
bath perfused with zero-magnesium aCSF as described. 1–3
tungsten electrodes (50 μm) were positioned at arbitrary
locations within the cerebral cortex. At least 10 s of
noise-free baseline recording was made prior to electrode
insertion for comparison with the 10 s immediately after
electrode insertion. Thereafter, zero-magnesium aCSF
perfusion was continued for 40 minutes at a constant flow
rate and no other interventions made. Each recording
was saved for later off-line analysis of the correlation
between electrode-induced activity and subsequent
SLE development (if any).Statistical analysis
Since not all data was normally distributed (Kolmogorov-
Smirnov test), non-parametric tests were used for all
comparisons and data presented as median (range). The
Mann–Whitney test was used for 2-sample analyses. For
multiple comparisons a p-value <0.008 was considered
significant, adjusted according to Bonferroni’s correction.
Otherwise, a p-value <0.05 was considered statistically
significant. Electrode-induced activity was calculated as
the change in summed power in the 10–50 Hz frequency
band over the 5 s immediately before and after electrode
insertion. This was then correlated with the pattern of
SLE activity that subsequently developed; namely the
peak in SLE amplitude, frequency and length. Because
quantification of SLE length is difficult to automate, this
parameter was derived from the manual selection of 5
sequential SLEs at the end of the recording. If no SLEs
developed, all parameters were given values of zero.
Voss et al. BMC Neuroscience 2013, 14:137 Page 6 of 6
http://www.biomedcentral.com/1471-2202/14/137Abbreviations
SLE: Seizure-like event; aCSF: Artificial cerebrospinal fluid.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CVK carried out the experiments and data analysis. LJV helped carry out the
experiments and data analysis; and drafted the paper. JWS helped with
editing the manuscript. All authors read and approved the final manuscript.
Acknowledgements
CVK was funded from a Research Assistant provided by Auckland Uniservices
Ltd. Auckland Uniservices Ltd also covered the consumable costs of the
study. LJV was funded by Waikato District Health Board and JWS by
Auckland University. None of the funding organizations had a direct role in
designing or implementing the study. The authors would also like to
acknowledge the Waikato University School of Engineering for providing the
laboratory space for the experiments.
Author details
1Anaesthesia Department, Waikato District Health Board, Hamilton 3240,
New Zealand. 2University of Amsterdam, Amsterdam 1012 ZA, The Netherlands.
3University of Auckland Waikato Clinical School, Hamilton 2340, New Zealand.
Received: 4 September 2013 Accepted: 31 October 2013
Published: 6 November 2013
References
1. Yamamoto C, McIlwain H: Electrical activities in thin sections from the
mammalian brain maintained in chemically-defined media in vitro.
J Neurochem 1966, 13:1333–1343.
2. Fountain SB, Hennes SK, Teyley TJ: Aspartame exposure and in vitro
hippocampal slice excitability and plasticity. Fundam Appl Toxicol 1988,
11:221–228.
3. Aitken PG, Breese GR, Dudek FF, Edwards F, Espanol MT, Larkman PM,
Lipton P, Newman GC, Nowak TS Jr, Panizzon KL, et al: Preparative
methods for brain slices: a discussion. J Neurosci Methods 1995,
59:139–149.
4. Lipton P, Aitken PG, Dudek FE, Eskessen K, Espanol MT, Ferchmin PA, Kelly JB,
Kreisman NR, Landfield PW, Larkman PM, et al: Making the best of brain
slices: comparing preparative methods. J Neurosci Methods 1995, 59:151–156.
5. Elbohouty M, Wilson MT, Voss LJ, Steyn-Ross DA, Hunt LA: In vitro electrical
conductivity of seizing and non-seizing mouse brain slices at 10 kHz.
Phys Med Biol 2013, 58:3599–3613.
6. Durand DM, Warman EN: Desynchronisation of epileptiform activity by
extracellular current pulses in rat hippocampal slices. J Physiol Lond 1994,
480:527–537.
7. Deshpande LS, Lou JK, Mian A, Blair RE, Sombati S, Attkisson E, DeLorenzo RJ:
Time course and mechanism of hippocampal neuronal death in an in vitro
model of status epilepticus: role of NMDA receptor activation and NMDA
dependent calcium entry. Eur J Pharmacol 2008, 583:73–83.
8. Kohling R, Vreugdenhil M, Bracci E, Jefferys JG: Ictal epileptiform activity is
facilitated by hippocampal GABAA receptor-mediated oscillations.
J Neurosci 2000, 20:6820–6829.
9. Martella G, De Persis C, Bonsi P, Natoli S, Cuomo D, Bernardi G, Calabresi P,
Pisani A: Inhibition of persistent sodium current fraction and voltage-gated
L-type calcium current by propofol in cortical neurons: implications for its
antiepileptic activity. Epilepsia 2005, 46:624–635.
10. Voss LJ, Baas CH, Hansson L, Li D, Sleigh JW: Investigation into the effect
of the general anaesthetic etomidate on local neuronal synchrony in the
mouse neocortical slice. Brain Res 2013, 1526:65–70.
11. Nowak LG, Bullier J: Spread of stimulating current in the cortical grey
matter of rat visual cortex studied on a new in vitro slice preparation.
J Neurosci Methods 1996, 67:237–248.
doi:10.1186/1471-2202-14-137
Cite this article as: Voss et al.: Quantitative investigation into methods
for evaluating neocortical slice viability. BMC Neuroscience 2013 14:137.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
